A comparison of bupivacaine lavage and diclofenac suppository effects on post-operative pain of laparascopic transabdominal pre-peritoneal herniorrhaphy: A randomized clinical trial study

Objectives: Injection of a topical anaesthetic has been proved to be helpful with reducing pain after laparoscopic herniorrhaphy. We aimed to assess the effect of bupivacaine lavage on postoperative pain and compare it with diclofenac suppository. In this randomized clinical trial, 60 patients - scheduled for laparoscopic herniorrhaphy - were enrolled and randomized into three groups of 20 each, including diclofenac suppository, bupivacaine lavage, and normal saline as a placebo.The patients were investigated for postoperative pain scores, vomiting, nausea, morphine request, and duration of hospitalization. Results: In the bupivacaine group, pain levels in recovery room, 4, 8 and 12 h after surgery, were significantly lower than diclofenac group; at time points of 16, 20 and 24 h after surgery, difference between two groups was not significant. Regarding vomiting and nausea, at time points of 1 and 3 h after surgery, results show no significant difference between the groups. Incident of infection, 1 h and 1 week after the surgery, was not significantly different among the groups. Duration of hospitalization in the bupivacaine group was much lower than the diclofenac group. Based on our results, use of the bupivacaine lavage can reduce postoperative pain in patients undergoing laparoscopic herniorrhaphy. Trial Registration Randomized clinical trial IRCT20180522039782N2; date of registration:14/10/2018 © 2020 The Author(s)

Active Air Injection Control to Enhance Performance of Hollow-bladed Axial Fan: A Numerical Study

Nowadays, axial fans participate in the most important areas of industry and research, including aviation, navy, wind tunnels, cooling towers, and even automobiles. Thus, more emphasis has been placed on improving their aerodynamic performances. It is important to notice that the parameters involved in designing a fan are mainly concerned with aeraulic power, torque and efficiency. This study investigates the utilization of flow control techniques to improve performances of an axial fan equipped with hollow blades, shroud, and hub. These features grant the fan crucial characteristics, namely, its lightweight and facilitate the blowing action by taking advantage on its hollow parts. The fan's performance is evaluated using a steady RANS numerical model with a k-ω SST turbulence closure, which was validated with experimental data. An active control air blowing through a slot was introduced with various positions and dimensions. The results demonstrate a significant improvement in the fan's performance, with an up to 56% increase in aeraulic power gain, accompanied by changes in the overall flow topology, noticed by closely analyzing the flow structure near the tip clearance

A Developed Structure of Step-Up DC/DC Converter by Using Coupled Inductor and Active Clamped Circuit

In this paper, a new structure of step-up dc-dc converter by using coupled inductor and active-clamped circuit is proposed. The proposed converter generates high voltage gain in comparison with the conventional dc-dc converters. Duo to using active-clamped circuit in the proposed topology the voltage stress on main switch is reduced. In addition the zero voltage switching (ZVS) in ON-state of main switch is obtained. In this paper the performance of the proposed structure is investigated in continues current mode (CCM) and discontinues current mode (DCM). Moreover, the voltage gain in CCM and DCM operations are calculated. To prove the correctness operation and also the given equations, the simulation results in PSCAD/EMTDC software are used

Fragmented QRS and subclinical left ventricular dysfunction in individuals with preserved ejection fraction: A speckle-tracking echocardiographic study

Introduction: Fragmented QRS (fQRS) complex on routine 12-lead electrocardiogram (ECG) predicts adverse outcomes in patients with cardiovascular diseases. In addition, it has been found to be associated with subclinical myocardial dysfunction in chronic diseases. We sought to investigate the relationship between the presence of fQRS with the myocardial functions in individuals free from known systemic cardiovascular diseases. Methods: In a case-control study, we evaluated normal individuals from March 2017 to February 2018. All participants underwent a 2-dimensional transthoracic echocardiographic examination using tissue Doppler imaging (TDI) and speckle-tracking echocardiography. In addition, all participants were examined using a 12-lead surface ECG, and patients with fQRS and a group of age- and sex-matched controls without fQRS were enrolled in our study. Results: The patients' mean age was 40.3 ± 10.7 and 35.4 ± 11.2 years in fQRS-positive and fQRS-negative groups, respectively (P =.110). Patients with fQRS had significantly lower values of apical left ventricular global longitudinal strain (LV GLS) in 2-chamber (16.9 ± 2.5 vs. 20.5 ± 3.3, P <.001), 4-chamber (16.9 ± 3.4 vs. 20.1 ± 3, P =.001), LAX views (17.7 ± 2.8 vs. 20.8 ± 3.5, P =.001), and averaged LV GLS (17 ± 2.6 vs. 20.4 ± 2.7, P <.001) values compared to patients without fQRS. In a multivariate analysis, averaged LV GLS and smoking history were independent predictors for positive fQRS. Conclusion: The presence of fQRS on 12-lead ECG in healthy population was associated with lower values of LV GLS compared to normal individuals without fQRS. © 2019 The Authors. Journal of Arrhythmia published by John Wiley & Sons Australia, Ltd on behalf of Japanese Heart Rhythm Society

The Antinociceptive Effects of Rosuvastatin in Chronic Constriction Injury Model of Male Rats

Introduction: According to studies, statins possess analgesics and anti-inflammatory properties. In the present study, we examined the antinociceptive, anti-inflammatory and antioxidative effects of rosuvastatin in an experimental model of Chronic Constriction Injury (CCI). Methods: Our study was conducted on four groups; sham, CCI (the control group), CCI+rosuvastatin (i.p. 5 mg/kg), and CCI+rosuvastatin (i.p. 10 mg/kg). We performed heat hyperalgesia, cold and mechanical allodynia tests on the 3rd, 7th, 14th, and 21st after inducing CCI. Blood samples were collected to measure the serum levels of Tumor Necrosis Factor (TNF)-α, and Interleukin (IL)-6. Rats' spinal cords were also examined to measure tissue concentration of Malondialdehyde (MDA), Superoxide Dismutase (SOD), and Glutathione Peroxidase (GPx) enzymes. Results: Our findings showed that CCI resulted in significant increase in heat hyperalgesia, cold and mechanical allodynia on the 7th, 14th and 21st day. Rosuvastatin use attenuated the CCI-induced hyperalgesia and allodynia. Rosuvastatin use also resulted in reduction of TNF-α, IL-6, and MDA levels. However, rosuvastatin therapy increased the concentration of SOD and GPx in the CCI+Ros (5 mg/kg) and the CCI+Ros (10 mg/kg) groups compared to the CCI group. Conclusion: Rosuvastatin attenuated the CCI-induced neuropathic pain and inflammation. Thus, antinociceptive effects of rosuvastatin might be channeled through inhibition of inflammatory biomarkers and antioxidant propertie

Research Paper: The antinociceptive effects of rosuvastatin in chronic constriction injury model of male rats

Introduction: According to studies, statins possess analgesics and anti-inflammatory properties. In the present study, we examined the antinociceptive, anti-inflammatory and antioxidative effects of rosuvastatin in an experimental model of Chronic Constriction Injury (CCI). Methods: Our study was conducted on four groups; sham, CCI (the control group), CCI+rosuvastatin (i.p. 5 mg/kg), and CCI+rosuvastatin (i.p. 10 mg/kg). We performed heat hyperalgesia, cold and mechanical allodynia tests on the 3rd, 7th, 14th, and 21st after inducing CCI. Blood samples were collected to measure the serum levels of Tumor Necrosis Factor (TNF)-α, and Interleukin (IL)-6. Rats' spinal cords were also examined to measure tissue concentration of Malondialdehyde (MDA), Superoxide Dismutase (SOD), and Glutathione Peroxidase (GPx) enzymes. Results: Our findings showed that CCI resulted in significant increase in heat hyperalgesia, cold and mechanical allodynia on the 7th, 14th and 21st day. Rosuvastatin use attenuated the CCI-induced hyperalgesia and allodynia. Rosuvastatin use also resulted in reduction of TNF-α, IL-6, and MDA levels. However, rosuvastatin therapy increased the concentration of SOD and GPx in the CCI+Ros (5 mg/kg) and the CCI+Ros (10 mg/kg) groups compared to the CCI group. Conclusion: Rosuvastatin attenuated the CCI-induced neuropathic pain and inflammation. Thus, antinociceptive effects of rosuvastatin might be channeled through inhibition of inflammatory biomarkers and antioxidant properties

Rotational Molding of Polyamide-12 Nanocomposites: Modeling of the Viscoelastic Behavior

Nowadays, polyamide 12 (PA-12) is considered as an interesting polymer in the rotomolding process to manufacture different pieces like the liner part in the storage hydrogen tank (type IV). In this study, the pure polyamide-12 and PA12 pieces, incorporated with 0.5%, 1% and 3% wt Nano Carbon Black (NCB), were manufactured by the rotomolding process. Different rotomolding parameters such as heating temperature, time of heating, and cooling rate have been optimized to obtain the ideal piece. The effect of volume fraction of NCB in terms of physicochemical and mechanical properties has been studied. Afterward, the optimal volume fraction of NCB is revealed using different characterization methods. The tensile results specified the addition of NCBs until 0.5% improved the tensile behavior. The addition of NCBs more than 0.5% decreases the mechanical properties in terms of failure stress and strain, while it has no significant effect on the elastic modulus of PA-12. The bi-parabolic the Perez model has been used to study the viscoelastic behavior of PA-12 using the Cole-Cole method. The constants of the Perez model indicate a good correlation between viscoelastic experimental results and the model used

The Incidence Rate of Vasovagal Reactions and Its Effective Factors among Blood Donors in Mashhad Blood Transfusion Centers

Aims: Vasovagal reaction is one of the most common complications of blood donation, this study was conducted to determine the prevalence of vasovagal reactions and its effective factors among blood donors in Mashhad blood transfusion centers. Materials & Methods: This case-control study was performed on 657 blood donors in Mashhad's four blood transfusion centers during 6 months. The donors who had vasovagal reactions were in the case group (218 cases), and 439 donors who did not respond to vasovagal were in the control group. The age, BMI, blood pressure, pulse rate, hematocrit and vasovagal response variables were studied. Data were analyzed by SPSS 11.5 using Chi-square and Mann-Whitney tests. Findings: The incidence of vasovagal reactions in the six months was 2.16%. The mean age in the case group was significantly lower than the control group (p<0.001). Vasovagal reactions were significantly higher in women and in first-time donors, as well as in those with anxiety and in subjects with lower BMI (p<0.001). The mean reduction in arterial pressure after blood donation was significantly higher in the case group than in the control group (p<0.001). Conclusion: The incidence of vasovagal reactions is dependent on several factors, including age, sex, BMI, and blood pressure, and with more care from high-risk donors, it can be approximately prevented from vasovagal reaction and increased the possibility of returning to blood donation

The antinociceptive effects of rosuvastatin in chronic constriction injury model of male rats

Introduction: According to studies, statins possess analgesics and anti-inflammatory properties. In the present study, we examined the antinociceptive, anti-inflammatory and antioxidative effects of rosuvastatin in an experimental model of Chronic Constriction Injury (CCI). Methods: Our study was conducted on four groups; sham, CCI (the control group), CCI+rosuvastatin (i.p. 5 mg/kg), and CCI+rosuvastatin (i.p. 10 mg/kg). We performed heat hyperalgesia, cold and mechanical allodynia tests on the 3rd, 7th, 14th, and 21st after inducing CCI. Blood samples were collected to measure the serum levels of Tumor Necrosis Factor (TNF)-α, and Interleukin (IL)-6. Rats' spinal cords were also examined to measure tissue concentration of Malondialdehyde (MDA), Superoxide Dismutase (SOD), and Glutathione Peroxidase (GPx) enzymes. Results: Our findings showed that CCI resulted in significant increase in heat hyperalgesia, cold and mechanical allodynia on the 7th, 14th and 21st day. Rosuvastatin use attenuated the CCI-induced hyperalgesia and allodynia. Rosuvastatin use also resulted in reduction of TNF-α, IL-6, and MDA levels. However, rosuvastatin therapy increased the concentration of SOD and GPx in the CCI+Ros (5 mg/kg) and the CCI+Ros (10 mg/kg) groups compared to the CCI group. Conclusion: Rosuvastatin attenuated the CCI-induced neuropathic pain and inflammation. Thus, antinociceptive effects of rosuvastatin might be channeled through inhibition of inflammatory biomarkers and antioxidant properties

Vitamin D status in irritable bowel syndrome and the impact of supplementation on symptoms: what do we know and what do we need to know?

BACKGROUND: Low vitamin D status is associated with risk of colorectal cancer and has been implicated in inflammatory bowel disease. Irritable bowel syndrome (IBS) is a chronic, relapsing, functional bowel disorder. A nascent literature suggests a role for vitamin D in IBS, but this has not been collated or critiqued. To date, seven studies have been published: four observational studies and three randomised controlled trials (RCTs). All observational studies reported that a substantial proportion of the IBS population was vitamin D deficient. Two intervention studies reported improvement in IBS symptom severity scores and quality of life (QoL) with vitamin D supplementation. There are limited data around the role of vitamin D in IBS. CONCLUSIONS: The available evidence suggests that low vitamin D status is common among the IBS population and merits assessment and rectification for general health reasons alone. An inverse correlation between serum vitamin D and IBS symptom severity is suggested and vitamin D interventions may benefit symptoms. However, the available RCTs do not provide strong, generalisable evidence; larger and adequately powered interventions are needed to establish a case for therapeutic application of vitamin D in IBS